Central Pacific Bank - Trust Division’s BioMarin Pharmaceuticals BMRN Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$306K	Hold	5,350	–	–	0.03%	393
2026 Q1	$302K	Sell	5,350 -400	-7%	-$23.3K	0.04%	375
2025 Q4	$342K	Buy	5,750 +500	+10%	+$27.2K	0.04%	347
2025 Q3	$284K	Buy	5,250 +500	+11%	+$28.6K	0.03%	373
2025 Q2	$261K	Buy	4,750 +400	+9%	+$23.6K	0.03%	397
2025 Q1	$308K	Sell	4,350 -200	-4%	-$13.5K	0.04%	353
2024 Q4	$299K	Hold	4,550	–	–	0.04%	373
2024 Q3	$320K	Hold	4,550	–	–	0.04%	358
2024 Q2	$375K	Buy	4,550 +500	+12%	+$41.6K	0.04%	389
2024 Q1	$353K	Buy	+4,050	New	+$363K	0.04%	422

Other funds holding BMRN

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Central Pacific Bank - Trust Division's BMRN Position: Q2 2026 in Review

Central Pacific Bank - Trust Division held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 5,350 shares worth $306K. The position accounts for 0.03% of the portfolio, ranked #393.

Central Pacific Bank - Trust Division first reported a position in BMRN in Q1 2024 and has held it in 10 quarters since. The position peaked at $375K in Q2 2024. 97 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Central Pacific Bank - Trust Division held 5,350 shares of BioMarin Pharmaceuticals worth $306K as of Q2 2026.
Central Pacific Bank - Trust Division left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
BioMarin Pharmaceuticals made up 0.03% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #393 holding.
Central Pacific Bank - Trust Division first reported a position in BioMarin Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
Central Pacific Bank - Trust Division's BioMarin Pharmaceuticals position peaked at $375K in Q2 2024.
97 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.